ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Wearable Bioelectronics for Home-Based Monitoring and Treatment of Muscle Atrophy.
Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Wearable Bioelectronics for Home-Based Monitoring and Treatment of Muscle Atrophy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Muscle atrophy is a chronic disease caused by multiple factors, and there is currently no effective treatment or reliable diagnostic method. Similar review articles focus on the induction and summary of the pathogenic mechanism and traditional treatment of muscle atrophy. However, soft, portable, and efficient bioelectronic devices that are expected to achieve home diagnosis and treatment of the disease are more concerned, hoping to realize complete home care as soon as possible. The article includes: 1) Classification and summary of muscle atrophy-related diseases and pathways; 2) Mechanical sensors, electromyography (EMG), electrochemical sensors, bioelectrical impedance analysis (BIA), and ultrasonic patches for monitoring muscle atrophy; 3) Transcutaneous electrotherapy, bioelectronic implants, bioelectronic drug delivery devices, and ExoMuscles for treating muscle atrophy; 4) Electrode-tissue interface problems in muscle atrophy bioelectronics and feasible solutions. 5) Recommendations and prospects for integrated bioelectronic systems for home diagnosis and treatment of muscle atrophy in the future.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.